Document is current
Any future updates will be listed below
-
Authors
Karim, Mustafa Abdul
Al-Baz, Nadeen
Ouanes, Sami
Khalil, Ali
Assar, Ahmed H.
Alsiddiqi, Abdulkarim
Dabbous, Zeinab
Zirie, Mahmoud
Woodruff, Peter
Malik, Rayaz A.
Haddad, Peter M. https://orcid.org/0000-0003-3383-9294
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 17 February 2021
First Online: 12 March 2021
Ethics approval and consent to participate
: The study proposal was approved by the Medical Research Center (MRC) and Institutional Review Board (IRB) at HMC (proposal ID: MRC-01-19-051). The IRB confirmed that patient consent was not required as the data used in the study was obtained from existing medical records. All necessary administrative approvals were obtained to access the data and the study was conducted in accordance with the HMC research governance framework.
: Not applicable.
: In the last 3 years, PMH reports personal fees from Janssen, Lundbeck, Otsuka, NewBridge Pharmaceuticals and Sunovion, outside the submitted work. RAM reports personal fees for educational lectures from Novo Nordisk, Pfizer, Lilly and Proctor and Gamble. The other authors declare that they have no competing interests.
